Esco Technologies [ESE] vs Cognex [CGNX] Detailed Stock Comparison
Esco Technologies
NYSE
Loading...
Cognex
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Esco Technologies wins in 12 metrics, Cognex wins in 8 metrics, with 0 ties. Esco Technologies appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Esco Technologies | Cognex | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 42.01 | 57.01 | Esco Technologies |
| Price-to-Book Ratio | 3.88 | 4.58 | Esco Technologies |
| Debt-to-Equity Ratio | 22.13 | 5.52 | Cognex |
| PEG Ratio | 39.91 | 42.76 | Esco Technologies |
| EV/EBITDA | 23.09 | 40.84 | Esco Technologies |
| Profit Margin (TTM) | 11.01% | 13.13% | Cognex |
| Operating Margin (TTM) | 8.81% | 17.44% | Cognex |
| EBITDA Margin (TTM) | 8.81% | 17.44% | Cognex |
| Return on Equity | 9.66% | 8.10% | Esco Technologies |
| Return on Assets (TTM) | 5.78% | 4.11% | Esco Technologies |
| Free Cash Flow (TTM) | $79.29M | $134.04M | Cognex |
| Dividend Yield | 0.18% | 0.96% | Cognex |
| 1-Year Return | 62.99% | 6.76% | Esco Technologies |
| Price-to-Sales Ratio (TTM) | 4.63 | 7.41 | Esco Technologies |
| Enterprise Value | $5.13B | $6.72B | Cognex |
| EV/Revenue Ratio | 4.78 | 7.23 | Esco Technologies |
| Gross Profit Margin (TTM) | 41.13% | 67.39% | Cognex |
| Revenue per Share (TTM) | $42 | $5 | Esco Technologies |
| Earnings per Share (Diluted) | $4.57 | $0.72 | Esco Technologies |
| Beta (Stock Volatility) | 1.23 | 1.47 | Esco Technologies |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Esco Technologies vs Cognex Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Esco Technologies | 1.99% | -1.98% | -0.81% | 16.11% | 19.74% | 44.35% |
| Cognex | -1.09% | 1.45% | 29.86% | 45.58% | 8.24% | 15.85% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Esco Technologies | 62.99% | 112.10% | 109.52% | 412.33% | 533.11% | 241.06% |
| Cognex | 6.76% | -14.23% | -38.72% | 123.57% | 732.19% | 435.75% |
Performance & Financial Health Analysis: Esco Technologies vs Cognex
| Metric | ESE | CGNX |
|---|---|---|
| Market Information | ||
| Market Cap | $4.96B | $6.89B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 161,310 | 2,607,209 |
| 90 Day Avg. Volume | 177,597 | 2,043,183 |
| Last Close | $193.65 | $40.91 |
| 52 Week Range | $111.06 - $198.34 | $22.67 - $44.17 |
| % from 52W High | -2.36% | -7.38% |
| All-Time High | $198.42 (Jul 17, 2025) | $101.82 (Feb 08, 2021) |
| % from All-Time High | -2.40% | -59.82% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.09% | 0.04% |
| Quarterly Earnings Growth | -0.10% | 0.12% |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | 0.13% |
| Operating Margin (TTM) | 0.09% | 0.17% |
| Return on Equity (TTM) | 0.10% | 0.08% |
| Debt to Equity (MRQ) | 22.13 | 5.52 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $49.46 | $8.97 |
| Cash per Share (MRQ) | $2.16 | $1.36 |
| Operating Cash Flow (TTM) | $166.58M | $190.80M |
| Levered Free Cash Flow (TTM) | $106.27M | $166.53M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.18% | 0.96% |
| Last 12-Month Dividend | $0.32 | $0.39 |
Valuation & Enterprise Metrics Analysis: Esco Technologies vs Cognex
| Metric | ESE | CGNX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 42.01 | 57.01 |
| Forward P/E | 39.91 | 42.76 |
| PEG Ratio | 39.91 | 42.76 |
| Price to Sales (TTM) | 4.63 | 7.41 |
| Price to Book (MRQ) | 3.88 | 4.58 |
| Market Capitalization | ||
| Market Capitalization | $4.96B | $6.89B |
| Enterprise Value | $5.13B | $6.72B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.78 | 7.23 |
| Enterprise to EBITDA | 23.09 | 40.84 |
| Risk & Other Metrics | ||
| Beta | 1.23 | 1.47 |
| Book Value per Share (MRQ) | $49.46 | $8.97 |
Financial Statements Comparison: Esco Technologies vs Cognex
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ESE | CGNX |
|---|---|---|
| Revenue/Sales | $265.52M | $216.04M |
| Cost of Goods Sold | $156.30M | $71.71M |
| Gross Profit | $109.22M | $144.32M |
| Research & Development | N/A | $34.73M |
| Operating Income (EBIT) | $43.07M | $26.09M |
| EBITDA | $56.67M | $32.49M |
| Pre-Tax Income | $40.50M | $27.80M |
| Income Tax | $9.47M | $4.20M |
| Net Income (Profit) | $31.03M | $23.60M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ESE | CGNX |
|---|---|---|
| Cash & Equivalents | $57.40M | $143.74M |
| Total Current Assets | $660.75M | $577.68M |
| Total Current Liabilities | $322.02M | $183.96M |
| Long-Term Debt | $103.95M | $63.43M |
| Total Shareholders Equity | $1.28B | $1.45B |
| Retained Earnings | $1.13B | $405.95M |
| Property, Plant & Equipment | $416.20M | $166.19M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ESE | CGNX |
|---|---|---|
| Operating Cash Flow | $44.16M | $47.37M |
| Capital Expenditures | N/A | $-2.50M |
| Free Cash Flow | $11.08M | $38.00M |
| Debt Repayment | $-48.00M | N/A |
| Common Stock Repurchase | $0 | $-102.23M |
Short Interest & Institutional Ownership Analysis
| Metric | ESE | CGNX |
|---|---|---|
| Shares Short | 343,200 | 5.74M |
| Short Ratio | 1.57 | 3.35 |
| Short % of Float | 0.02% | 0.04% |
| Average Daily Volume (10 Day) | 161,310 | 2,607,209 |
| Average Daily Volume (90 Day) | 177,597 | 2,043,183 |
| Shares Outstanding | 25.75M | 170.43M |
| Float Shares | 25.67M | 160.31M |
| % Held by Insiders | 0.00% | 0.00% |
| % Held by Institutions | 1.00% | 0.99% |
Dividend Analysis & Yield Comparison: Esco Technologies vs Cognex
| Metric | ESE | CGNX |
|---|---|---|
| Last 12-Month Dividend | $0.32 | $0.39 |
| Last 12-Month Dividend Yield | 0.18% | 0.96% |
| 3-Year Avg Annual Dividend | $0.32 | $0.32 |
| 3-Year Avg Dividend Yield | 0.08% | 0.18% |
| 3-Year Total Dividends | $0.96 | $0.95 |
| Ex-Dividend Date | Apr 02, 2025 | Aug 14, 2025 |